drugset / Trial / NCT06389214
A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Randomized, Double-Masked, Vehicle-Controlled Parallel Group Clinical Trial to Assess Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease
Timeline
- Start
- 2024-04-09
- Primary completion
- 2024-06-11
- Completion
- 2024-06-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Reproxalap | Other / unclassified | 0.25 % | — |